Review Article

Medicolegal Considerations with Intravenous Tissue Plasminogen Activator in Stroke: A Systematic Review

Table 3

Frequency of factors favoring defendant.

Factors favoring defendantsNumber of cases (total: 32), percentage (%) of casesVerdict

Documented contraindication/discussion with the family16, 50%Defendant: 12, 75%
Plaintiff: 4, 25%
Expert witness8, 25%Defendant: 8, 100%
Plaintiff: 0
Beyond 3 hrs when diagnosed 5, 15.6%Defendant: 2, 40%
Plaintiff: 2, 40%
NA: 1, 20%
“TPA protocol in hospital”3, 9.4%Defendant: 1, 33.3%
Plaintiff: 2, 66.7%
Informed consent2, 6.3%Defendant: 2, 100%
Plaintiff: 0
Discussion with patient and family2, 6.3%Defendant: 2, 100%
Plaintiff: 0
No specific time of onset of symptoms2, 6.3%Defendant: 2, 100%
Plaintiff: 0
tPA not available in hospital1, 3.1%Defendant: 1, 100%
Plaintiff: 0
Timely transfer to other hospital3, 9.3%Defendant: 3, 100%
Plaintiff: 0